Prediction  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
avian  ||| S:14 E:20 ||| NNS
influenza  ||| S:20 E:30 ||| VBP
A  ||| S:30 E:32 ||| DT
binding  ||| S:32 E:40 ||| JJ
preference  ||| S:40 E:51 ||| NN
to  ||| S:51 E:54 ||| TO
human  ||| S:54 E:60 ||| JJ
receptor  ||| S:60 E:69 ||| NN
using  ||| S:69 E:75 ||| VBG
conformational  ||| S:75 E:90 ||| JJ
analysis  ||| S:90 E:99 ||| NN
of  ||| S:99 E:102 ||| IN
receptor  ||| S:102 E:111 ||| NN
bound  ||| S:111 E:117 ||| VBN
to  ||| S:117 E:120 ||| TO
hemagglutinin  ||| S:120 E:134 ||| VB
It  ||| S:134 E:137 ||| PRP
is  ||| S:137 E:140 ||| VBZ
known  ||| S:140 E:146 ||| VBN
that  ||| S:146 E:151 ||| IN
the  ||| S:151 E:155 ||| DT
highly  ||| S:155 E:162 ||| RB
pathogenic  ||| S:162 E:173 ||| JJ
avian  ||| S:173 E:179 ||| NNS
influenza  ||| S:179 E:189 ||| VBP
A  ||| S:189 E:191 ||| DT
virus  ||| S:191 E:197 ||| NN
H5N1  ||| S:197 E:202 ||| CD
binds  ||| S:202 E:208 ||| NNS
strongly  ||| S:208 E:217 ||| RB
and  ||| S:217 E:221 ||| CC
with  ||| S:221 E:226 ||| IN
high  ||| S:226 E:231 ||| JJ
specificity  ||| S:231 E:243 ||| NN
to  ||| S:243 E:246 ||| TO
the  ||| S:246 E:250 ||| DT
avian-type  ||| S:250 E:261 ||| JJ
receptor  ||| S:261 E:270 ||| NN
by  ||| S:270 E:273 ||| IN
its  ||| S:273 E:277 ||| PRP$
hemagglutinin  ||| S:277 E:291 ||| JJ
surface  ||| S:291 E:299 ||| NN
protein ||| S:299 E:306 ||| NN
.  ||| S:306 E:308 ||| .
This  ||| S:308 E:313 ||| DT
specificity  ||| S:313 E:325 ||| NN
is  ||| S:325 E:328 ||| VBZ
normally  ||| S:328 E:337 ||| RB
a  ||| S:337 E:339 ||| DT
barrier  ||| S:339 E:347 ||| NN
to  ||| S:347 E:350 ||| TO
viral  ||| S:350 E:356 ||| JJ
transmission  ||| S:356 E:369 ||| NN
from  ||| S:369 E:374 ||| IN
birds  ||| S:374 E:380 ||| NNS
to  ||| S:380 E:383 ||| TO
humans ||| S:383 E:389 ||| NNS
.  ||| S:389 E:391 ||| .
However ||| S:391 E:398 ||| RB
,  ||| S:398 E:400 ||| ,
strains  ||| S:400 E:408 ||| NNS
may  ||| S:408 E:412 ||| MD
emerge  ||| S:412 E:419 ||| VB
with  ||| S:419 E:424 ||| IN
mutated  ||| S:424 E:432 ||| JJ
hemagglutinin ||| S:432 E:445 ||| NN
,  ||| S:445 E:447 ||| ,
potentially  ||| S:447 E:459 ||| RB
changing  ||| S:459 E:468 ||| VBG
the  ||| S:468 E:472 ||| DT
receptor  ||| S:472 E:481 ||| JJ
binding  ||| S:481 E:489 ||| JJ
preference  ||| S:489 E:500 ||| NN
from  ||| S:500 E:505 ||| IN
avian  ||| S:505 E:511 ||| VBG
to  ||| S:511 E:514 ||| TO
human-type ||| S:514 E:524 ||| JJ
.  ||| S:524 E:526 ||| .
This  ||| S:526 E:531 ||| DT
hypothesis  ||| S:531 E:542 ||| NN
has  ||| S:542 E:546 ||| VBZ
been  ||| S:546 E:551 ||| VBN
proven  ||| S:551 E:558 ||| VBN
correct ||| S:558 E:565 ||| JJ
,  ||| S:565 E:567 ||| ,
since  ||| S:567 E:573 ||| IN
viral  ||| S:573 E:579 ||| JJ
isolates  ||| S:579 E:588 ||| NN
from  ||| S:588 E:593 ||| IN
Vietnam  ||| S:593 E:601 ||| NNP
and  ||| S:601 E:605 ||| CC
Thailand  ||| S:605 E:614 ||| NNP
have  ||| S:614 E:619 ||| VBP
been  ||| S:619 E:624 ||| VBN
found  ||| S:624 E:630 ||| VBN
which  ||| S:630 E:636 ||| WDT
have  ||| S:636 E:641 ||| VBP
increased  ||| S:641 E:651 ||| VBN
selectivity  ||| S:651 E:663 ||| VBN
toward  ||| S:663 E:670 ||| IN
the  ||| S:670 E:674 ||| DT
human  ||| S:674 E:680 ||| JJ
cell  ||| S:680 E:685 ||| NN
receptor ||| S:685 E:693 ||| NN
.  ||| S:693 E:695 ||| .
The  ||| S:695 E:699 ||| DT
change  ||| S:699 E:706 ||| NN
in  ||| S:706 E:709 ||| IN
binding  ||| S:709 E:717 ||| JJ
preference  ||| S:717 E:728 ||| NN
is  ||| S:728 E:731 ||| VBZ
due  ||| S:731 E:735 ||| JJ
to  ||| S:735 E:738 ||| TO
mutation ||| S:738 E:746 ||| VB
,  ||| S:746 E:748 ||| ,
which  ||| S:748 E:754 ||| WDT
can  ||| S:754 E:758 ||| MD
be  ||| S:758 E:761 ||| VB
computationally  ||| S:761 E:777 ||| JJ
modelled ||| S:777 E:785 ||| NN
.  ||| S:785 E:787 ||| .
The  ||| S:787 E:791 ||| DT
aim  ||| S:791 E:795 ||| NN
of  ||| S:795 E:798 ||| IN
this  ||| S:798 E:803 ||| DT
study  ||| S:803 E:809 ||| NN
is  ||| S:809 E:812 ||| VBZ
to  ||| S:812 E:815 ||| TO
further  ||| S:815 E:823 ||| RB
explore  ||| S:823 E:831 ||| VB
whether  ||| S:831 E:839 ||| IN
computational  ||| S:839 E:853 ||| JJ
simulation  ||| S:853 E:864 ||| NN
could  ||| S:864 E:870 ||| MD
be  ||| S:870 E:873 ||| VB
used  ||| S:873 E:878 ||| VBN
as  ||| S:878 E:881 ||| IN
a  ||| S:881 E:883 ||| DT
prediction  ||| S:883 E:894 ||| NN
tool  ||| S:894 E:899 ||| NN
for  ||| S:899 E:903 ||| IN
host  ||| S:903 E:908 ||| NN
type  ||| S:908 E:913 ||| NN
selectivity  ||| S:913 E:925 ||| NN
in  ||| S:925 E:928 ||| IN
emerging  ||| S:928 E:937 ||| VBG
variants ||| S:937 E:945 ||| NNS
.  ||| S:945 E:947 ||| .
Molecular  ||| S:947 E:957 ||| JJ
dynamics  ||| S:957 E:966 ||| JJ
simulation  ||| S:966 E:977 ||| NN
was  ||| S:977 E:981 ||| VBD
employed  ||| S:981 E:990 ||| VBN
to  ||| S:990 E:993 ||| TO
study  ||| S:993 E:999 ||| VB
the  ||| S:999 E:1003 ||| DT
interactions  ||| S:1003 E:1016 ||| NN
between  ||| S:1016 E:1024 ||| IN
receptor  ||| S:1024 E:1033 ||| NN
models  ||| S:1033 E:1040 ||| NNS
and  ||| S:1040 E:1044 ||| CC
hemagglutinin  ||| S:1044 E:1058 ||| JJ
proteins  ||| S:1058 E:1067 ||| NNS
from  ||| S:1067 E:1072 ||| IN
H5N1  ||| S:1072 E:1077 ||| CD
strains  ||| S:1077 E:1085 ||| NNS
A ||| S:1085 E:1086 ||| DT
/ ||| S:1086 E:1087 ||| NNP
Duck ||| S:1087 E:1091 ||| NNP
/ ||| S:1091 E:1092 ||| NNP
Singapore ||| S:1092 E:1101 ||| NNP
/ ||| S:1101 E:1102 ||| CD
3 ||| S:1102 E:1103 ||| CD
/ ||| S:1103 E:1104 ||| CD
97 ||| S:1104 E:1106 ||| CD
,  ||| S:1106 E:1108 ||| ,
mutated  ||| S:1108 E:1116 ||| VBG
A ||| S:1116 E:1117 ||| DT
/ ||| S:1117 E:1118 ||| NNP
Duck ||| S:1118 E:1122 ||| NNP
/ ||| S:1122 E:1123 ||| NNP
Singapore ||| S:1123 E:1132 ||| NNP
/ ||| S:1132 E:1133 ||| CD
3 ||| S:1133 E:1134 ||| CD
/ ||| S:1134 E:1135 ||| CD
97  ||| S:1135 E:1138 ||| CD
( ||| S:1138 E:1139 ||| -LRB-
Q222L ||| S:1139 E:1144 ||| NNP
,  ||| S:1144 E:1146 ||| ,
G224S ||| S:1146 E:1151 ||| NNP
,  ||| S:1151 E:1153 ||| ,
Q222L ||| S:1153 E:1158 ||| CD
/ ||| S:1158 E:1159 ||| CD
G224S ||| S:1159 E:1164 ||| CD
) ||| S:1164 E:1165 ||| -RRB-
,  ||| S:1165 E:1167 ||| ,
A ||| S:1167 E:1168 ||| DT
/ ||| S:1168 E:1169 ||| NNP
Thailand ||| S:1169 E:1177 ||| NNP
/ ||| S:1177 E:1178 ||| CD
1 ||| S:1178 E:1179 ||| CD
( ||| S:1179 E:1180 ||| -LRB-
KAN-1 ||| S:1180 E:1185 ||| NNP
) ||| S:1185 E:1186 ||| -RRB-
/ ||| S:1186 E:1187 ||| CD
2004 ||| S:1187 E:1191 ||| CD
,  ||| S:1191 E:1193 ||| ,
and  ||| S:1193 E:1197 ||| CC
mutated  ||| S:1197 E:1205 ||| VBN
A ||| S:1205 E:1206 ||| DT
/ ||| S:1206 E:1207 ||| NNP
Thailand ||| S:1207 E:1215 ||| NNP
/ ||| S:1215 E:1216 ||| CD
1 ||| S:1216 E:1217 ||| CD
( ||| S:1217 E:1218 ||| -LRB-
KAN-1 ||| S:1218 E:1223 ||| NNP
) ||| S:1223 E:1224 ||| -RRB-
/ ||| S:1224 E:1225 ||| CD
2004  ||| S:1225 E:1230 ||| CD
( ||| S:1230 E:1231 ||| -LRB-
L129V ||| S:1231 E:1236 ||| CD
/ ||| S:1236 E:1237 ||| CD
A134V ||| S:1237 E:1242 ||| CD
) ||| S:1242 E:1243 ||| -RRB-
.  ||| S:1243 E:1245 ||| .
The  ||| S:1245 E:1249 ||| DT
avian  ||| S:1249 E:1255 ||| JJ
receptor  ||| S:1255 E:1264 ||| NN
was  ||| S:1264 E:1268 ||| VBD
represented  ||| S:1268 E:1280 ||| VBN
by  ||| S:1280 E:1283 ||| IN
Sia  ||| S:1283 E:1287 ||| NNP
alpha ||| S:1287 E:1292 ||| NNS
( ||| S:1292 E:1293 ||| -LRB-
2,3 ||| S:1293 E:1296 ||| NNP
) ||| S:1296 E:1297 ||| -RRB-
Gal  ||| S:1297 E:1301 ||| NNP
substructure  ||| S:1301 E:1314 ||| NN
and  ||| S:1314 E:1318 ||| CC
human  ||| S:1318 E:1324 ||| JJ
receptor  ||| S:1324 E:1333 ||| NN
by  ||| S:1333 E:1336 ||| IN
Sia  ||| S:1336 E:1340 ||| NNP
alpha ||| S:1340 E:1345 ||| NNS
( ||| S:1345 E:1346 ||| -LRB-
2,6 ||| S:1346 E:1349 ||| NNP
) ||| S:1349 E:1350 ||| -RRB-
Gal ||| S:1350 E:1353 ||| NNP
.  ||| S:1353 E:1355 ||| .
The  ||| S:1355 E:1359 ||| DT
glycoside  ||| S:1359 E:1369 ||| JJ
binding  ||| S:1369 E:1377 ||| JJ
conformation  ||| S:1377 E:1390 ||| NN
was  ||| S:1390 E:1394 ||| VBD
monitored  ||| S:1394 E:1404 ||| VBN
throughout  ||| S:1404 E:1415 ||| IN
the  ||| S:1415 E:1419 ||| DT
simulations  ||| S:1419 E:1431 ||| NN
since  ||| S:1431 E:1437 ||| IN
high  ||| S:1437 E:1442 ||| JJ
selectivity  ||| S:1442 E:1454 ||| NN
toward  ||| S:1454 E:1461 ||| IN
a  ||| S:1461 E:1463 ||| DT
particular  ||| S:1463 E:1474 ||| JJ
host  ||| S:1474 E:1479 ||| NN
occurs  ||| S:1479 E:1486 ||| VBZ
when  ||| S:1486 E:1491 ||| WRB
the  ||| S:1491 E:1495 ||| DT
sialoside  ||| S:1495 E:1505 ||| NN
bound  ||| S:1505 E:1511 ||| VBN
with  ||| S:1511 E:1516 ||| IN
the  ||| S:1516 E:1520 ||| DT
near-optimized  ||| S:1520 E:1535 ||| JJ
conformation ||| S:1535 E:1547 ||| NN
.  ||| S:1547 E:1549 ||| .
The  ||| S:1549 E:1553 ||| DT
simulation  ||| S:1553 E:1564 ||| JJ
results  ||| S:1564 E:1572 ||| NNS
showed  ||| S:1572 E:1579 ||| VBD
all  ||| S:1579 E:1583 ||| DT
hemagglutinin  ||| S:1583 E:1597 ||| JJ
proteins  ||| S:1597 E:1606 ||| NNS
used  ||| S:1606 E:1611 ||| VBD
the  ||| S:1611 E:1615 ||| DT
same  ||| S:1615 E:1620 ||| JJ
set  ||| S:1620 E:1624 ||| NN
of  ||| S:1624 E:1627 ||| IN
amino  ||| S:1627 E:1633 ||| JJ
acid  ||| S:1633 E:1638 ||| NN
residues  ||| S:1638 E:1647 ||| NNS
to  ||| S:1647 E:1650 ||| TO
bind  ||| S:1650 E:1655 ||| VB
with  ||| S:1655 E:1660 ||| IN
the  ||| S:1660 E:1664 ||| DT
glycoside ||| S:1664 E:1673 ||| NN
;  ||| S:1673 E:1675 ||| :
however ||| S:1675 E:1682 ||| RB
,  ||| S:1682 E:1684 ||| ,
some  ||| S:1684 E:1689 ||| DT
mutations  ||| S:1689 E:1699 ||| NNS
alter  ||| S:1699 E:1705 ||| VBP
linkage  ||| S:1705 E:1713 ||| JJ
preferences ||| S:1713 E:1724 ||| NNS
.  ||| S:1724 E:1726 ||| .
Preference  ||| S:1726 E:1737 ||| NN
toward  ||| S:1737 E:1744 ||| IN
human-type  ||| S:1744 E:1755 ||| JJ
receptors  ||| S:1755 E:1765 ||| NN
is  ||| S:1765 E:1768 ||| VBZ
associated  ||| S:1768 E:1779 ||| VBN
with  ||| S:1779 E:1784 ||| IN
a  ||| S:1784 E:1786 ||| DT
positive  ||| S:1786 E:1795 ||| JJ
torsion  ||| S:1795 E:1803 ||| JJ
angle ||| S:1803 E:1808 ||| NN
,  ||| S:1808 E:1810 ||| ,
while  ||| S:1810 E:1816 ||| IN
avian-type  ||| S:1816 E:1827 ||| JJ
receptor  ||| S:1827 E:1836 ||| NN
preference  ||| S:1836 E:1847 ||| NN
is  ||| S:1847 E:1850 ||| VBZ
associated  ||| S:1850 E:1861 ||| VBN
with  ||| S:1861 E:1866 ||| IN
a  ||| S:1866 E:1868 ||| DT
negative  ||| S:1868 E:1877 ||| JJ
torsion  ||| S:1877 E:1885 ||| JJ
angle ||| S:1885 E:1890 ||| NN
.  ||| S:1890 E:1892 ||| .
According  ||| S:1892 E:1902 ||| VBG
to  ||| S:1902 E:1905 ||| TO
the  ||| S:1905 E:1909 ||| DT
conformation  ||| S:1909 E:1922 ||| JJ
analysis  ||| S:1922 E:1931 ||| NN
of  ||| S:1931 E:1934 ||| IN
the  ||| S:1934 E:1938 ||| DT
bound  ||| S:1938 E:1944 ||| JJ
receptors ||| S:1944 E:1953 ||| NNS
,  ||| S:1953 E:1955 ||| ,
we  ||| S:1955 E:1958 ||| PRP
could  ||| S:1958 E:1964 ||| MD
predict  ||| S:1964 E:1972 ||| VB
the  ||| S:1972 E:1976 ||| DT
relative  ||| S:1976 E:1985 ||| JJ
selectivity  ||| S:1985 E:1997 ||| NN
in  ||| S:1997 E:2000 ||| IN
accordance  ||| S:2000 E:2011 ||| NN
with  ||| S:2011 E:2016 ||| IN
in  ||| S:2016 E:2019 ||| IN
vitro  ||| S:2019 E:2025 ||| JJ
experimental  ||| S:2025 E:2038 ||| JJ
data  ||| S:2038 E:2043 ||| NNS
when  ||| S:2043 E:2048 ||| WRB
disaccharides  ||| S:2048 E:2062 ||| JJ
receptor  ||| S:2062 E:2071 ||| NN
analogs  ||| S:2071 E:2079 ||| NNS
were  ||| S:2079 E:2084 ||| VBD
used ||| S:2084 E:2088 ||| VBN
.  ||| S:2088 E:2090 ||| .
